Jean F. Holloway Esq.
Net Worth
Last updated:
What is Jean F. Holloway Esq. net worth?
The estimated net worth of Ms. Jean F. Holloway Esq. is at least $6,334,209 as of 31 Aug 2021. She owns shares worth $1,547,818 as insider, has earned $500,051 from insider trading and has received compensation worth at least $4,286,340 in Artivion, Inc..
What is the salary of Jean F. Holloway Esq.?
Ms. Jean F. Holloway Esq. salary is $476,260 per year as Senior Vice President, Gen. Counsel, Chief Compliance Officer & Corporation Sec. in Artivion, Inc..
How old is Jean F. Holloway Esq.?
Ms. Jean F. Holloway Esq. is 68 years old, born in 1957.
What stocks does Jean F. Holloway Esq. currently own?
As insider, Ms. Jean F. Holloway Esq. owns shares in one company:
Company | Title | Shares | Price per share | Total value |
---|---|---|---|---|
Artivion, Inc. (CRY) | Senior Vice President, Gen. Counsel, Chief Compliance Officer & Corporation Sec. | 86,567 | $17.88 | $1,547,818 |
What does Artivion, Inc. do?
Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. It offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, pulmonary, and general surgical applications; On-X prosthetic aortic and mitral heart valve, and On-X ascending aortic prosthesis; cardiac preservation services; PhotoFix, a bovine pericardial patch; and E-vita OPEN PLUS and E-vita OPEN NEO, a hybrid stent graft system. The company also provides E-xtra DESIGN ENGINEERING products for the treatment of aortic vascular diseases; E-nside, an off-the-shelf stent graft for the treatment of thoraco-abdominal disease; E-vita THORACIC 3G for the endovascular treatment of thoracic aortic aneurysms; E-nya, a thoracic stent graft system for the minimally invasive repair of lesions of the descending aorta; E-ventus BX, a balloon-expandable peripheral stent graft for the endovascular treatment of renal and pelvic arteries; E-liac to treat aneurysmal iliac arteries, and aneurysmal iliac side branches; and E-tegra, an abdominal aortic aneurysms stent graft system. In addition, it offers synthetic vascular grafts for use in open aortic and peripheral vascular surgical procedures; PerClot, an absorbable powdered hemostat for use in surgical procedures; and cardiac laser therapy products, such as SolarGen 2100s Console and SoloGrip III disposable handpieces. Further, the company sells CryoVein femoral vein and CryoArtery femoral artery vascular preservation services; CarbonAid CO2 diffusion catheters and Chord-X ePTFE sutures for mitral chordal replacement; and ascyrus medical dissection stents, as well as offers pyrolytic carbon coating services to other medical device manufacturers. The company serves physicians, hospitals, and other healthcare facilities, as well as cardiac, vascular, thoracic, and general surgeons. The company was formerly known as CryoLife, Inc. and changed its name to Artivion Inc. in January 2022. Artivion Inc. was founded in 1984 and is headquartered in Kennesaw, Georgia.
Jean F. Holloway Esq. insider trading
Artivion, Inc.
Ms. Jean F. Holloway Esq. has made 12 insider trades between 2016-2021, according to the Form 4 filled with the SEC. Most recently she sold 663 units of CRY stock worth $17,566 on 31 Aug 2021.
The largest trade she's ever made was exercising 13,236 units of CRY stock on 5 May 2021. As of 31 Aug 2021 she still owns at least 86,567 units of CRY stock.
Artivion key executives
Artivion, Inc. executives and other stock owners filed with the SEC:
- Mr. David Ashley Lee CPA, CPA (60) Executive Vice President, Chief Operating Officer & Chief Financial Officer
- Mr. James Patrick Mackin (58) Chairman, Pres & Chief Executive Officer
- Mr. John E. Davis (60) Senior Vice President of Global Sales & Marketing
- Ms. Jean F. Holloway Esq. (68) Senior Vice President, Gen. Counsel, Chief Compliance Officer & Corporation Sec.